Using kinesio tape with decongestive therapy for lower limb fibrosis after cellulitis
Effect of Modified Complete Decongestive Therapy on Lower Limbs Fibrosis Post Cellulitis
This study is testing whether using kinesio tape along with a special therapy can help people with lower limb fibrosis after cellulitis feel better and improve their quality of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 45 Years to 55 Years |
| Sex | All |
| Sponsor | Cairo University Academic / other |
| Locations | 1 site (Cairo) |
| Trial ID | NCT05661123 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of combining kinesio tape with complete decongestive therapy on patients suffering from lower limb fibrosis following cellulitis. The approach aims to reduce limb volume, improve skin extensibility, and enhance overall quality of life by addressing symptoms such as pain and tightness. Participants will undergo a two-phase rehabilitative intervention, focusing first on decongestion and then on maintenance to sustain improvements. The goal is to achieve better outcomes in a shorter time frame and with fewer therapy sessions, ultimately benefiting the patients' functional capacity and productivity.
Who should consider this trial
Good fit: Ideal candidates are males and females aged 45 to 55 with stage 2 lower limb lymphedema who are medically stable and have been post cellulitis for at least 2 weeks.
Not a fit: Patients with unstable cardiovascular issues, advanced lymphedema stages, or acute infections may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve the quality of life for patients with lower limb fibrosis post cellulitis.
How similar studies have performed: While the combination of kinesio tape and decongestive therapy is a novel approach, similar studies have shown positive outcomes with decongestive therapy alone.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: The patient will be according the following criteria:- 1. Males and females with Lower limb lymphedema Stage 2. 2. Age will range from45 to 55years old. 3. BMI \<40 (kg/m2). 4. All patients will be clinically and medically stable when attending the study. 5. Patients free from any acute conditions. 6. Post cellulitis for at least 2 weeks. Exclusion Criteria: 1. Unstable cardiovascular problems. 2. Altered mental status or poor cognition. 3. Lower limb ischemia (ABI ≤0.8). 4. Lower limb lymphedema stage 3\&4. 5. Acute deep venous thrombosis. 6. Any acute infection. 7. Patients with orthopedic or neurological limitations to exercise. 8. Any lower limb acute ulcer or arterial wounds.
Where this trial is running
Cairo
- Al Sahel teaching hospital — Cairo, Egypt (Recruiting)
Study contacts
- Study coordinator: Eva Nakhla
- Email: dr-evamagdy@hotmail.comm
- Phone: 0201220264801
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.